PatientsVille.com Logo

CONSTIPATION and Mirtazapine

PatientsVille

CONSTIPATION Symptoms and Causes

Constipation means that a person has three or fewer bowel movements in a week. The stool can be hard and dry. Sometimes it is painful to pass. At one time or another, almost everyone gets constipated. In most cases, it lasts a short time and is not serious.

There are many things you can do to prevent Constipation. They include

  • Eating more fruits, vegetables and grains, which are high in fiber
  • Drinking plenty of water and other liquids
  • Getting enough exercise
  • Taking time to have a bowel movement when you need to
  • Using laxatives only if your doctor says you should
  • Asking your doctor if medicines you take may cause Constipation

It's not important that you have a bowel movement every day. If your bowel habits change, however, check with your doctor.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Check out the latest treatments for CONSTIPATION

CONSTIPATION treatment research studies

Mirtazapine clinical trials, surveys and public health registries


Find Drug Side Effect reports



Mirtazapine Side Effects

Completed Suicide (237)
Confusional State (206)
Hyponatraemia (180)
Depression (160)
Overdose (148)
Anxiety (147)
Fall (136)
Dizziness (130)
Agitation (130)
Condition Aggravated (123)
Somnolence (117)
Insomnia (113)
Headache (110)
Serotonin Syndrome (109)
Suicidal Ideation (107)
Fatigue (105)
Loss Of Consciousness (104)
Convulsion (103)
Aggression (103)
Suicide Attempt (100)
Nausea (96)
Oedema Peripheral (93)
Dyspnoea (92)
Weight Increased (90)
Tachycardia (90)
Tremor (84)
Malaise (82)
Vomiting (75)
Restless Legs Syndrome (75)
Myalgia (73)
Alanine Aminotransferase Increased (72)
Cardiac Arrest (71)
Inappropriate Antidiuretic Hormone Secretion (71)
Feeling Abnormal (70)
Toxicity To Various Agents (69)
Asthenia (69)
Diarrhoea (67)
Syncope (62)
Hyperhidrosis (61)
Neuroleptic Malignant Syndrome (61)
Pain In Extremity (61)
Electrocardiogram Qt Prolonged (60)
Pyrexia (59)
Aspartate Aminotransferase Increased (58)
Pulmonary Embolism (57)
Arthralgia (56)
Hypotension (56)
Irritability (56)
Pain (55)
Gait Disturbance (54)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

i have been on citalopram and amatripolineand fluxaitne i have been on 15mg of mirtazapine and tryed 30mg the doc has put me on 45mg and i asked if these tablets dont work what is next hes said shrink as i have tryed all the ones he said but i have

My symptoms were tired, weak, unable to sleep. Was prescribed half of a 15 MG Mirtazapine nightly to help me sleep. Has this drug been successful used as a sleeping aid?

The above comment is too stupid, I actually LOLed at you Pete... lol you gave it 2 days and your complaining about the side-effects? and on 15 mgs? LMAO!!! It takes couple weeks at least to cope with the side-effects; just like m

48 year old male, I have suffered depression all my life. Have used SSRI's for the last ten years with good but mixed results. Last year lost my job due to an episode where I ended up throwing my monitor across the office and have not been able to wo

After a nasty experience with citalapram i was advised by my doc to try mirtazapine and it has suitedme very well. only side effect i canreport is an appetite increase. However as i don't carry much weight that isnt a problem.&

Back pain

Been on 90mg mirtazapine for 6 years twice the recomended dose is this considered safe

Body covered in hives

Does mirtazapine have muscles side effects?

Dziala i to jak......polecam

I am taking Suboxone and have had constipation, fatigue and very bad chills and sweats at night. Even during the day, I sometimes feel like I am hot and cold at the same time. I am wondering though, if this is Menopause? The fatigue is so extrem

I toke imodium 3 days ago 9th july 2010 and today is 12 july 2010 and I am scared now I have not been to toilet for three days, it suppose to help you with your diaherea and then gives you constipation may be the initial dose should be one

I ASKED MY GP FOR CHAMPIX AS I HAD SUDDENLY DECIDED AFTER SMOKING FOR 22YEARS. I TRIED PATCHES IN THE PAST ADN COLD TURKEY. PATCHES CAUSED CHEST PAIN, BLOOTING, CONSTIPATION,NAUSEA,SWEATS,

<strong>Constipation, Fluid build up under my eyes, Depressed</strong>

After having stilnoct for atleast 6 months, there is occuring of head heaviness,fever, dry mouth,constipation, lack of appetite.

After taking it for two days it createde a lot of stomach problems, belching, acidity, bloating, constipation and what not.

Am taking klonopin for restless leg syndrome (1 mg. at night) this causese debilitating daytime fatigue and constipation

Back pains,dizziness,constipation and stomach pains

Beano contains Magnesium Stearate. Magnesium Stearate is toxic.Now wonder some of you had diarrhea,stomach pains,and constipation.Magnesium Stearate will suppress the immune system.No thanks beano,I would rather fart!!

Been taking 3x the recommended dose of Pepto-Bismol because I always have constipation. what are your veiws of me taken Pepto Bismol for constipation? What might some other options be?And Pepto- bismol is not really even medicine what would you respo

CONSTIPATION Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Not yet recruiting Innovative Toilet Seat Test for Patients With Symptoms of Constipation and/or Emptying Disorders
Condition: Constipation
Interventions: Device: Experimental toilet seat;   Device: Standard toilet seat
Outcome Measures: Improvement in bowel movement frequency;   Improvement in quality of life
2 Recruiting Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children
Conditions: Abdominal Pain;   Constipation - Functional
Interventions: Dietary Supplement: Administration of L.reuteri in children with abdominal pain;   Dietary Supplement: Administration of placebo in children with abdominal pain;   Dietary Supplement: Administration of L.reuteri in children with Constipation;   Dietary Supplement: Administration of placebo in children with Constipation
Outcome Measures: Intensity of abdominal pain;   Severity of chronic Constipation;   Intensity of abdominal pain after treatment;   Severity of chronic Constipation after treatment
3 Recruiting Perineal Self-Acupressure
Conditions: Chronic Constipation;   Constipation;   Hemorrhoids
Interventions: Behavioral: Perineal Self-Acupressure;   Behavioral: Educational Control
Outcome Measures: Patient Assessment of Constipation Quality of Life Questionnaire;   Modified Bowel Function Index and Hemorrhoid Questionnaire;   SF-12
4 Not yet recruiting A Trial of Three Types of Enemas Used to Treat Functional Constipation in Children
Condition: Functional Constipation
Interventions: Drug: Sodium phosphate enema;   Drug: Normal saline enema;   Drug: Mineral oil enema
Outcome Measure: Change in pain scores following administration of enema
5 Unknown  Lubiprostone in Patients With Multiple Sclerosis Associated Constipation
Conditions: Multiple Sclerosis;   Constipation
Interventions: Drug: Lubiprostone;   Drug: Placebo
Outcome Measures: To determine the effect of lubiprostone 24 mcg twice daily on spontaneous bowel movements in patients with MS-associated Constipation;   To determine the safety of lubiprostone based on adverse event (AE) type, frequency, and severity. Hypothesis: AE type, frequency, and severity will be comparable in lubiprostone and placebo treated patients.
6 Recruiting Functional Magnetic Stimulation Enhances Gastrointestinal Motility in Patients With Chronic Constipation
Condition: Constipation
Intervention: Device: Functional Magnetic Stimulation
Outcome Measures: Effectiveness of FMS in accelerating the gastric emptying in patients with non-neurological Constipation after 5-week conditioning protocol;   Effectiveness of FMS in reducing the colonic transit time in patients with non-neurological Constipation after a 5 week conditioning period
7 Recruiting A Study to Evaluate the Effects of a Natural Supplement in Adults With Chronic Functional Constipation
Condition: Constipation
Intervention: Dietary Supplement: Natural Fibre Supplement
Outcome Measures: Number of bowel movements per week;   Stool consistency, as measured by the Bristol Stool Form Scale;   Quality of life as measured by the Quality of Life Questionnaire (PAC-QOL);   Constipation symptoms as measured by PAC-SYM;   Laxative use by subjects with functional Constipation
8 Not yet recruiting Feasibility Study of Oral Naloxone for Treatment of Methadone-induced Constipation
Condition: Constipation
Interventions: Drug: Naloxone;   Drug: Placebo
Outcome Measures: Severity of Constipation symptoms;   Severity of opioid withdrawal symptoms
9 Recruiting MiraLAX Versus Placebo to Prevent Constipation Following Urogynecologic Surgery
Condition: Post Procedural Constipation
Interventions: Drug: MiraLax;   Drug: Placebo;   Drug: Rescue Laxative
Outcome Measures: Time to first postoperative bowel movement;   Other postoperative medication use;   Evaluation of symptoms and quality of life related to Constipation;   Symptoms of Over-Effectiveness;   Evaluation of symptoms and quality of life related to Constipation 6-weeks postoperatively
10 Recruiting Trial on Short-chain Fructooligosaccharides, Microbiota, and Constipation in Adults
Condition: Functional Constipation
Interventions: Dietary Supplement: sc-FOS 2g/day;   Dietary Supplement: sc-FOS 4g/day;   Dietary Supplement: sc-FOS 8g/day;   Dietary Supplement: Placebo
Outcome Measures: Stool frequency (Number of complete bowel movements per day);   Stool consistency (Bristol Stool Scale);   Severity of symptoms (Constipation Scoring System; CSS);   Quality of Life (Patient Assessment of Constipation Quality of Life; PAC-QoL)
11 Recruiting Reflexology for Chronic Constipation
Condition: Chronic Constipation
Intervention: Procedure: Reflexology
Outcome Measures: Change in complete spontaneous bowel movements (CSBM)/week from baseline to 24 weeks;   Increase of at least one CSBM per week from baseline for 9 or more weeks during the 24-week treatment period;   Stool frequency/Week (CSBMs and spontaneous bowel movements (SBMs);   Stool consistency/week using the 7- point Bristol Stool Form Scale, during the 24 weeks of the study period;   Severity of straining using a 5-point ordinal scale (1 indicates not at all; 5 an extreme amount).;   Abdominal discomfort, using a 5-point ordinal scale (1 indicates not at all; 5 an extreme amount);   Severity of bloating, using a 5-point ordinal scale (1 indicates not at all; 5 an extreme amount);   Constipation severity (using a 5-point ordinal scale, with higher scores indicating greater severity);   Constipation relief (based on a 7-point balanced scale, with 1 indicating complete relief, 4 indicating no change, and 7 indicating very severe Constipation);   Satisfaction with the trial results, using a 5-point ordinal scale;   Health related quality of life (using the validated Patient Assessment of Constipation Quality of Life instrument (PAC-QOL);   Treatment side effects
12 Unknown  Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation.
Condition: Chronic Constipation, Methanogenesis
Interventions: Drug: Lubiprostone;   Drug: Lubiprostone Control
Outcome Measure: Effect of Lubiprostone in patients with Chronic Constipation
13 Unknown  Multistrain Probiotic for Functional Constipation
Condition: Functional Constipation
Interventions: Dietary Supplement: High dose Multistrain probiotic, 100 billion cfu/day;   Dietary Supplement: Low dose Multistrain probiotic, 15 billion cfu/day
Outcome Measures: Whole gut transit time;   Patient Assessment of Constipation Quality of Life (PAC-QOL);   Wexner Constipation Score (WCS);   Gastrointestinal Symptom Rating Scale (GSRS);   Stool frequency;   Stool consistency;   Fecal probiotic count;   Adverse events
14 Recruiting Effectiveness of Standing Frame on Constipation in Children With Cerebral Palsy
Conditions: Cerebral Palsy;   Quadriplegia;   Diplegia;   Constipation
Intervention: Device: standing-frame
Outcome Measures: bowel evacuation frequency;   Bowel evacuation inductions frequency
15 Recruiting The Efficacy and Safety Study of Electro-acupuncture for Severe Chronic Functional Constipation
Condition: Constipation
Interventions: Device: electro-acupuncture;   Device: sham electro-acupuncture
Outcome Measures: Change of weekly average CSBM from baseline;   The proportion of participants having three or more CSBMs on average per week;   Change of weekly average CSBMs from baseline;   Change of weekly average SBMs from baseline;   Change of average weekly stool consistency assessment from baseline;   Change of average weekly degree of difficulty in defecation from baseline;   PAC-QOL;   incidence of adverse events;   Usage of medicine for Constipation
16 Recruiting Quality of Life in Children and Adolescents With Chronic Functional Constipation: Educational Action Effects
Condition: Chronic Functional Constipation
Intervention: Behavioral: Educational action with focal group
Outcome Measures: The improvement in the quality of life on participants after the intervention;   The improvement in clinical parameters of chronic functional Constipation
17 Recruiting Efficacy of Sacral Nerve Modulation in Severe Refractory Constipation
Condition: Constipation
Intervention: Procedure: sacral nerve modulation
Outcome Measures: Percentage of patients showing a positive response to sacral nerve stimulation at 2 months;   Clinical characteristics, manometry data, Wexner score of responders to stimulation during the temporary stimulation test (period before the permanent implantation);   Clinical characteristics, manometry data, Wexner score of responders to short-term stimulation;   Efficacy of neuromodulation;   Manometry data, Wexner, QoL and EVA scores, time of colonic transit of responders to prolonged stimulation;   To evaluate the investigator opinion about the neuromodulation response, using the patient diary.
18 Recruiting Maintenance Treatment for Children With Constipation
Condition: Constipation
Interventions: Drug: Polyethylene glycol 3350;   Other: Placebo
Outcome Measures: Treatment recovery;   Usage of laxative
19 Unknown  Pilot Study of the Effect of Lactulose on Post Caesarean Section Constipation
Conditions: Constipation;   Abdominal Pain;   Nausea;   Vomiting
Intervention: Drug: Lactulose
Outcome Measures: Time in hours to passage of first stool post Caesarean Section.;   Frequency of abdominal pain between lactulose and non-lactulose groups.;   Frequency of nausea and vomiting between lactulose and non-lactulose groups
20 Not yet recruiting Assessing a Stool Symptom Screener in Patients With Chronic Opioid-Induced Constipation
Condition: Opioid-induced Constipation
Intervention:
Outcome Measure: Semi-structured discussion guide